Company: INDP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001641172-25-023499
Chunk: 15

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 15
---
 prices related to such prevailing market prices, including sales made directly on a national securities      
 exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents;               |
| ● | privately                                                                                                                              
 negotiated transactions;                                                                                                               |
| ● | through                                                                                                                                
 the writing or settlement of options or other hedging transactions entered into after the effective date of the registration statement 
 of which this prospectus is a part, whether through an options exchange or otherwise;                                                  |
| ● | broker-dealers                                                                                                                         
 may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share;                     |
| ● | a                                                                                                                                      
 combination of any of the above methods of disposition; or                                                                             |
| ● | any                                                                                                                                    
 other method permitted pursuant to applicable law.                                                                                     |

The selling stockholders may also sell shares under Rule 144 or Rule 904 under the Securities Act, if available, or Section 4(a)(1) under the Securities Act, rather than under this prospectus.

Broker-dealers engaged by the selling stockholders may arrange for other broker-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated. The selling stockholders do not expect these commissions and discounts to exceed what is customary in the types of transactions involved.

The selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell shares of common stock from time to time under this prospectus, or under a supplement or amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.

| 14 |

Upon being notified in writing by a selling stockholder that any material arrangement has been entered into with a broker-dealer for the sale of common stock through a block trade, special offering, exchange distribution or secondary distribution or a purchase by a broker or dealer, we will file a supplement to this prospectus, if required, pursuant to Rule 424(b) under the Securities Act, disclosing (i) the name of each such selling stockholder